Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: Results from the women's health initiative study of cognitive aging extension

Journal of the American Geriatrics Society

Volumn 58, Issue 7, 2010, Pages 1263-1271

  Espeland, Mark A ^a   Brunner, Robert L ^b   Hogan, Patricia E ^a   Rapp, Stephen R ^a   Coker, Laura H ^a   Legault, Claudine ^a   Granek, Iris ^c   Resnick, Susan M ^d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

cognitive function; postmenopausal hormone therapy; women's health

Indexed keywords

CONJUGATED ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; RISK FACTOR; SCORING SYSTEM; SMOKING; VERBAL MEMORY; WOMEN HEALTH INITIATIVE STUDY OF COGNITIVE AGING; WOMEN'S HEALTH; WORKING MEMORY;

AGED; AGED, 80 AND OVER; AGING; COGNITION; DEMENTIA; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; EARLY TERMINATION OF CLINICAL TRIALS; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDROXYPROGESTERONE ACETATE; PSYCHOLOGICAL TESTS;

EID: 77954344707     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02953.x     Document Type: Article

References (37)

1. Rapp S, Espeland MA, Shumaker SA et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2003 289 : 2663 2672.
2. Espeland MA, Rapp SR, Shumaker SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women. JAMA 2004 291 : 2959 2968.
3. Resnick SM, Coker LH, Maki PM et al. The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004 1 : 440 450.
4. Resnick SM, Maki PM, Rapp SR et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect: The Women's Health Initiative Study of Cognitive Aging (WHISCA). J Clin Endocrinol Metabol 2006 91 : 1802 1810.
5. Resnick SM, Espeland MA, An Y et al. Effects of conjugated equine estrogens on cognition and affect in surgically menopausal women. J Clin Endocrinol Metab 2009 94 : 4152 4161.
6. Resnick SR, Espeland MA, Jaramillo SA et al. Effects of postmenopausal hormone therapy on regional brain volumes in older women: The Women's Health Initiative Magnetic Resonance Imaging Study (WHIMS-MRI). Neurology 2009 72 : 135 142.
7. Shumaker SA, Reboussin BA, Espeland MA et al. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998 19 : 604 621.
8. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998 19 : 61 109.
9. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 : 321 333.
10. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004 291 : 1701 1712.
11. Kuse AR. Familial resemblances for cognitive abilities from two test batteries in Hawaii [Unpublished doctoral dissertation], University of Colorado, Boulder, 1977.
12. Benton A. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968 6 : 53 60.
13. Newcombe F. Missile Wounds of the Brain. A Study of Psychological Deficits.
14. Benton AL, Eslinger PJ, Damasio AR. Normative observations on neuropsychological test performances in old age. J Clin Neuropsychol 1981 3 : 33 42.
15. Delis DC, Kramer JH, Kaplan E et al. California Verbal Learning Test - Research Edition.
16. Wechsler D. Weschler Adult Intelligence Scale - Revised.
17. Ekstrom RB, French JW, Harman HH. Manual for Kit of Factor-Referenced Cognitive Tests.
18. Halstead WC. Brain and Intelligence.
19. Teng EL, Chui HC. The Modified Mini Mental State (3MS) Examination. J Clin Psychiatry 1987 48 : 314 318.
20. Espeland MA, Tindle HA, Bushnell CA et al. Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci 2009 64A : 1243 1250.
21. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review. Front Neuroendocrinol 2008 29 : 88 113.
22. Lord C, Buss C, Lupien SJ et al. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users, and men: A possible window of opportunity effect. Neurobiol Aging 2008 29 : 95 101.
23. Suzuki S, Brown CM, Dela Cruz CD et al. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Assoc Sci U S A 2007 104 : 6013 6018.
24. Spencer JL, Waters MW, Romeo RD et al. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neruoendocrinol 2008 29 : 219 237.
25. Rozovsky I, Hoving S, Anderson CP et al. Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci Lett 2002 323 : 191 194.
26. Wassertheil-Smoller S, Hendrix SL, Limacher M et al. Effect of estrogen plus progestin on stroke in postmenopausal women. JAMA 2003 289 : 2673 2684.
27. Coker LH, Hogan PE, Bryan NR et al. The effects of postmenopausal hormone therapy on volumetric sub-clinical cerebrovascular disease: The Women's Health Initiative Memory Study - Magnetic Resonance Imaging Study (WHIMS-MRI). Neurology 2009 72 : 125 134.
28. Shumaker S, Legault C, Rapp S et al. The effects of estrogen plus progestin on the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study (WHIMS). JAMA 2003 289 : 2663 2674.
29. Shumaker SA, Legault C, Kuller L et al. Conjugated equine estrogen alone, pooled hormone therapy, and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Results from the Women's Health Initiative Memory Study. JAMA 2004 291 : 2947 2958.
30. Maki PM. A systematic review of clinical trials of hormone therapy on cognitive function. Ann N Y Acad Sci 2005 1052 : 182 197.
31. Maki PM, Sundermann E. Hormone therapy and cognitive function. Hum Reproduct Update 2009 15 : 667 681.
32. Voytko ML, Tinkler GP, Browne C et al. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. Am J Primatol 2009 71 : 794 801.
33. Lethaby A, Hogervorst E, Richards M et al. Hormone replacement therapy for cognitive function in postmenopausal women. The Cochrane Library;4:2008.
34. Laughlin GA, Kritz-Silverstein D, Barrett-Connor E. Higher endogenous levels predict four year decline in verbal fluency in postmenopausal women: The Rancho Bernardo Study. Clin Endocrinol 2010 72 : 99 106.
35. Shattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav 2007 51 : 587 596.
36. Thilers PP, Macdonald SW, Herlitz A. The association between endogenous free testosterone and cognitive performance: A population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology 2006 31 : 565 576.
37. Ockene JK, Barad DH, Cochrane BB et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005 294 : 183 193.